Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

por Ek, L, Gezelius, E, Bergman, B, Bendahl, P O, Anderson, H, Sundberg, J, Wallberg, M, Falkmer, U, Verma, S, Belting, M
Publicado 2018

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

por Gezelius, E., Flou Kristensen, A., Bendahl, P. O., Hisada, Y., Risom Kristensen, S., Ek, L., Bergman, B., Wallberg, M., Falkmer, U., Mackman, N., Pedersen, S., Belting, M.
Publicado 2018